ASGPR antibodies and uses thereof
US9771427B2 · kind B2 · utility
13Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 6, 2013 |
| Grant date | Sep 26, 2017 |
| Priority date | — |
| Expiry date | Oct 2, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/01
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to antibodies specific for asialoglycoprotein receptor (ASGPR) and their use for selectively delivering effector moieties that influence cellular activity. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies of the invention, and to methods of using them in the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.